# HAS-BLED Score Calculator (Bleeding Risk on Anticoagulation)
> Free HAS-BLED calculator for major bleeding risk in AFib patients on anticoagulation. Score + risk band. Based on Pisters 2010 and the ACC/AHA/HRS 2019 AFib guideline. Clinician decision support.

## Overview

The HAS-BLED score estimates one-year risk of major bleeding in patients with atrial fibrillation on oral anticoagulation. It uses nine binary components: hypertension (uncontrolled), abnormal renal function, abnormal liver function, prior stroke, bleeding history or predisposition, labile INR, age over 65, drugs (antiplatelet or NSAID), and excessive alcohol. The score ranges 0–9. The ACC/AHA/HRS 2019 atrial fibrillation update references HAS-BLED as one of several bleeding-risk frameworks to be weighed alongside CHA₂DS₂-VASc when deciding whether to start or continue anticoagulation.

## Who this is for

- Hospitalists weighing benefits vs bleeding risk before initiating DOACs
- Internal medicine residents on AF anticoagulation decisions
- Cardiology and primary care providers managing chronic AF

## How to interpret the result

| Score / band | Meaning |
|---|---|
| 0–1 | Low — major-bleeding risk is generally low; HAS-BLED rarely overrides anticoagulation. |
| 2 | Moderate — closer monitoring and modifiable-factor optimisation are commonly considered. |
| ≥ 3 | High — modifiable risk factors (BP, INR variability, NSAIDs, alcohol) should be addressed; HAS-BLED is not by itself a reason to withhold anticoagulation. |

## Cited source

**ACC/AHA/HRS 2019 Focused Update on Atrial Fibrillation** (2019) — ACC / AHA / HRS

_Primary publication:_ Pisters R et al., Chest 2010 (HAS-BLED original derivation)

## FAQs

### Does a high HAS-BLED score mean I should stop anticoagulation?

No. Major guidelines explicitly state HAS-BLED is not a reason to withhold anticoagulation; it identifies modifiable risk factors and prompts closer monitoring. The decision integrates HAS-BLED, CHA₂DS₂-VASc, and patient preferences.

### What HAS-BLED factors are modifiable?

Uncontrolled hypertension, labile INR (consider switching to a DOAC), concurrent NSAIDs/antiplatelets, and excessive alcohol use are commonly modifiable. Optimising these often reduces bleeding risk while anticoagulation continues.

### Is HAS-BLED valid for DOACs?

HAS-BLED was originally derived in warfarin patients. It is widely used for DOAC patients, though its original calibration was on warfarin. Verify against the current ACC/AHA/HRS guideline.

### How does HAS-BLED differ from ATRIA or ORBIT?

HAS-BLED, ATRIA, and ORBIT are three competing bleeding-risk scores. HAS-BLED has the most clinical familiarity and explicitly identifies modifiable factors. ATRIA and ORBIT have shown comparable performance in observational cohorts.

### Should I document HAS-BLED in the chart?

Documenting both CHA₂DS₂-VASc and a bleeding-risk score (HAS-BLED, ATRIA, or ORBIT) is generally considered best practice when initiating anticoagulation in AF. Verify your institutional documentation policy.

---
_Rounds AI is a citation-first clinical AI assistant. It supports clinical reasoning by surfacing cited information and is not a substitute for independent clinical judgement._